Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to India
Go back to Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to IndiaAMPIO PHARMACEUTICALS, Inc. (AMEX: AMPE) | Delayed: 0.24 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.24 | 52 Week High | $4.32 | |||
Open | $0.24 | 52 Week Low | $0.59 | |||
Day High | $0.24 | P/E | N/A | |||
Day Low | $0.24 | EPS | $-0.63 | |||
Volume | 2 |